The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Patterns and rates of exonic de novo mutations in autism spectrum disorders
Open accessAbstract
Autism spectrum disorders (ASD) are believed to have genetic and environmental origins, yet in only a modest fraction of individuals can specific causes be identified. To identify further genetic risk factors, here we assess the role of de novo mutations in ASD by sequencing the exomes of ASD cases and their parents (n = 175 trios). Fewer than half of the cases (46.3%) carry a missense or nonsense de novo variant, and the overall rate of mutation is only modestly higher than the expected rate. In contrast, the proteins encoded by genes that harboured de novo missense or nonsense mutations showed a higher degree of connectivity among themselves and to previous ASD genes as indexed by protein-protein interaction screens. The small increase in the rate of de novo events, when taken together with the protein interaction results, are consistent with an important but limited role for de novo point mutations in ASD, similar to that documented for de novo copy number variants. Genetic models incorporating these data indicate that most of the observed de novo events are unconnected to ASD; those that do confer risk are distributed across many genes and are incompletely penetrant (that is, not necessarily sufficient for disease). Our results support polygenic models in which spontaneous coding mutations in any of a large number of genes increases risk by 5- to 20-fold. Despite the challenge posed by such models, results from de novo events and a large parallel case–control study provide strong evidence in favour of CHD8 and KATNAL2 as genuine autism risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“TADA requires a mutational model (Sanders et al., 2012; Neale et al., 2012; Samocha et al., 2014) which accounts for gene size and sequence composition to obtain an expectation for mutations per gene, given sample size.”
From Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism (2020) · cites this paper as Neale et al., 2012
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“mutations in chromatin complexes have been observed in schizophrenia where synaptic gene regulation is disrupted, and these mutations are also high-confidence genetic risk factors for ASD”
From The clinical use of epigenetics in psychiatry: a narrative review of epigenetic mechanisms, key candidate genes, and precision psychiatry (2025) · cites this paper as [42]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These studies demonstrate the ability of new sequencing technologies to significantly advance our understanding of the genetic basis of ASD.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [8]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“One of the INH-M13 hub genes is CHD2, whose de novo variants have been identified in individuals with ASD.42,43”
From hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data (2023) · cites this paper as [43]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“One of the INH-M13 hub genes is CHD2, whose de novo variants have been identified in individuals with ASD.42,43”
From hdWGCNA identifies co-expression networks in high-dimensional transcriptomics data (2023) · cites this paper as [43]
Experimental — accuracy not yet measured
In the citing paper
“CNVs and SNPs have both been reported to play a major role in autism incidence (36–41).”
From Gene × Environment Interactions in Autism Spectrum Disorders: Role of Epigenetic Mechanisms (2014) · cites this paper as [38]
In the citing paper
“These estimates are similar to published results using somewhat different methods [1], [2].”
From Integrated Model of De Novo and Inherited Genetic Variants Yields Greater Power to Identify Risk Genes (2013) · cites this paper as [2]
In the citing paper
“Exome sequencing has uncovered de novo single nucleotide variations (SNVs) and insertion/deletion (indel) mutations that segregate with ASD.”
From Unifying Views of Autism Spectrum Disorders: A Consideration of Autoregulatory Feedback Loops (2016) · cites this paper as Neale et al., 2012
In the citing paper
“Hypomorphic, biallelic mutations, combined with CNVs and heterozygous stop mutations (Neale et al., 2012; O’Roak et al., 2012; Sanders et al., 2012) which completely inactivate one of two alleles, suggest that a common theme for ASD mutations in general might be partial loss of gene function and/or dosage sensitivity.”
From Using Whole-Exome Sequencing to Identify Inherited Causes of Autism (2013) · cites this paper as Neale et al., 2012
In the citing paper
“ASD is often due to newly arising gene copy number variants (CNVs) — such as a deletion or duplication of a region of a chromosome — or a rare mutation that arises in the germ cell, particularly in sperm of older fathers5–10.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [8]
In the citing paper
“In addition, very recent exome sequencing of parent-offspring trios has identified de novo exonic mutations in SCN2A, KATNAL2, CHD8, FOXP1, NTNG1, GRIN2B, LAMC3(refs 7–9), extending further the number of genes for which mutation may contribute to ASD.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [8]
In the citing paper
“References 7– 10 use exome and entire genome sequencing to demonstrate the importance of rare mutations in ASD and identify new genetic mutations associated with ASD.”
From Activity-dependent neuronal signalling and autism spectrum disorder (2013) · cites this paper as [8]
In the citing paper
“and also that the loci hit by these SNVs are highly heterogeneous”
From Sex differences in autism spectrum disorders (2013) · cites this paper as [48]
In the citing paper
“Together, results from these papers demonstrate a significant role for rare SNVs in genetic liability for ASD”
From Sex differences in autism spectrum disorders (2013) · cites this paper as [48]
In the citing paper
“finding a handful of genes that are recurrently hit by these rare variants”
From Sex differences in autism spectrum disorders (2013) · cites this paper as [48]
In the citing paper
“Exome and whole-genome sequencing studies have estimated at least another ∼6% contribution to ASD7–10,15”
From Convergence of genes and cellular pathways dysregulated in autism spectrum disorders (2014) · cites this paper as [8]
In the citing paper
“De novo SNVs in CHD2 have been reported in an ASD subject and in several individuals with a broad spectrum of neurodevelopmental disorders, including ID and epileptic encephalopathy8,49,50 (Figure S6).”
From Convergence of genes and cellular pathways dysregulated in autism spectrum disorders (2014) · cites this paper as [8]
In the citing paper
“and three other recent studies by Sanders et al.8, O’Roak et al.7 and Neale et al.23 (65 genes combined from all three; referred to as ‘SON-exomes’);”
From Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism (2014) · cites this paper as [23]
In the citing paper
“Genetic investigations in ASD have constructed seed-based networks with literature-curated PPIs to identify the convergence of ASD risk genes71,73.”
From Systems biology and gene networks in neurodevelopmental and neurodegenerative disorders (2015) · cites this paper as [73]
In the citing paper
“In summary, only three genes [CHD8, SCN2A, and synaptic Ras GTPase activating protein 1 (SYNGAP1)] had two independent truncating de novo mutations in any single study, and no gene had more than three mutations.”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [25]
In the citing paper
“Many strong neurobiological candidates have emerged from the genes disrupted by de novo mutations in these studies, including mutations in previously identified ASD/ID genes.”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [25]
In the citing paper
“Notably, however, a follow-up case-control study by Neale and colleagues of 935 cases found three additional truncating CHD8 mutations and one splice-site mutation in SCN2A, further strengthening the initial disease associations of these genes [25].”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [25]
In the citing paper
“Exome sequencing of ASD/ID families has revealed a significant excess of de novo mutations in probands when compared to unaffected siblings and has identified novel candidate genes contributing to the neurological deficits.”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [25]
In the citing paper
“We note that the strongest effects are observed for de novo loss-of-function (or truncating) mutations”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [25]
In the citing paper
“New exome sequencing technology has identified novel rare variants and has found that sporadic cases of ASD/ID are enriched for disruptive de novo mutations.”
From A de novo convergence of autism genetics and molecular neuroscience (2014) · cites this paper as [25]
In the citing paper
“To date, in addition to causal and highly penetrant genes and genomic loci identified before whole-exome sequencing (15,30), over 50 high-risk genes have emerged from the large-scale sequencing studies (21)(22)(23)(24)(25)(26), most under a model of autosomal dominant variation.”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [21]
In the citing paper
“Rare genetic risk variation identified to date, in contrast, has a very substantial effect on individual risk.Recent whole-exome sequencing analyses of large ASD cohorts (21)(22)(23)(24)(25)(26)(27)(28)(29) have expanded the repertoire of known genes harboring ASD-linked mutations”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [21]
In the citing paper
“At this point, it is clear that rare microscopically detectable chromosomal rearrangements (14,15), submicroscopic deletions or duplications (CNV or smaller structural variation) (27,(29)(30)(31)(32), single-nucleotide variation (SNV) and small deletions and duplications (indels) (21)(22)(23)(24)(25)(26)(33)(34)(35) all contribute to risk.”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [21]
In the citing paper
“Simulations based on the observed number of recurrently disrupted genes have estimated that there are some 600-1200 ASD risk genes (21,24,26,51).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [21]
In the citing paper
“Recent whole-exome sequencing analyses of large ASD cohorts (21)(22)(23)(24)(25)(26)(27)(28)(29) have expanded the repertoire of known genes harboring ASD-linked mutations that were previously identifiable only by traditional genetic approaches and targeted sequencing (14,15).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [21]
In the citing paper
“TBR1 has been implicated in ASD (21,22,25,26) and ID (73).”
From Genetics and genomics of autism spectrum disorder: embracing complexity (2015) · cites this paper as [21]
In the citing paper
“Qualitatively, recent studies of rare variants also find it challenging to distinguish risk variation from the background stochastic noise (12–15).”
From Individual common variants exert weak effects on the risk for autism spectrum disorders (2012) · cites this paper as [14]
In the citing paper
“Albeit rare, de novo mutations have emerged as substantial contributors to ASD risk [83, 165, 166, 254, 261, 309].”
From Autism spectrum disorder: neuropathology and animal models (2017) · cites this paper as [254]
In the citing paper
“Recent exome sequencing studies only reported one de novo SHANK2 mutation out of 965 patients [32], [36], [37]”
From Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments (2014) · cites this paper as [37]
In the citing paper
“no truncating coding-sequence variation within SHANK1 and SHANK3”
From Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments (2014) · cites this paper as [37]
In the citing paper
“However, a central finding from these papers was that only a minority of cases had a de novo putatively functional variant”
From Genetic architectures of psychiatric disorders: the emerging picture and its implications (2012) · cites this paper as [84]
In the citing paper
“Three recent papers describe the results from exome sequencing of ~600 trios, and identify roles for de novo exonic mutations in SCN2A, KATNAL2, and CHD8 in the pathogenesis of ASD. 83–85”
From Genetic architectures of psychiatric disorders: the emerging picture and its implications (2012) · cites this paper as [84]
In the citing paper
“Intriguingly, all three studies noted an increased rate of de novo exonic mutations in older parents (with the mutations generally being of paternal origin), 83–85”
From Genetic architectures of psychiatric disorders: the emerging picture and its implications (2012) · cites this paper as [84]
In the citing paper
“Unexpectedly, simplex and multiplex ASD pedigrees show relatively similar de novo mutation rates for SV 80,81 and exonic variation. 83–85”
From Genetic architectures of psychiatric disorders: the emerging picture and its implications (2012) · cites this paper as [84]
In the citing paper
“pathway analyses reported in two of the studies found that genes containing de novo exonic variation were more closely connected in reference to protein-protein interaction databases. 83,84”
From Genetic architectures of psychiatric disorders: the emerging picture and its implications (2012) · cites this paper as [84]
In the citing paper
“estimates from de novo exonic mutations (similar to those from SV data) suggest that ASD is highly polygenic (estimates ranged from 400–1000 genes). 84,85”
From Genetic architectures of psychiatric disorders: the emerging picture and its implications (2012) · cites this paper as [84]
In the citing paper
“The published results for ASD 83–85 and unpublished data on SCZ suggest these issues will be important and underscore the need for sequencing studies to have the same emphasis on statistical rigor and large sample sizes that has enabled GWAS to realize success for multiple psychiatric disorders. 154”
From Genetic architectures of psychiatric disorders: the emerging picture and its implications (2012) · cites this paper as [84]
In the citing paper
“Many studies of complex neuropsychiatric disorders have also concluded that disease-causing variants are often clustered in protein-interaction networks with a high degree of connectivity among themselves and that these clustered networks are often enriched with functional pathways relevant to brain functions [72–80].”
From An integrated analysis of genes and functional pathways for aggression in human and rodent models (2019) · cites this paper as [72]
In the citing paper
“These three studies report de novo mutations with a twofold to fourfold increase in de novo nonsense variants among affected subjects over that expected by chance”
From Autism risk factors: genes, environment, and gene-environment interactions (2012) · cites this paper as [36]
In the citing paper
“two of these studies report that spontaneous changes are correlated with paternal age”
From Autism risk factors: genes, environment, and gene-environment interactions (2012) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Self-citationA method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194
Self-citationFast and accurate long-read alignment with Burrows-Wheeler transform.
Li, H., & Durbin, R. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp698 · Cited by 12,063
A framework for variation discovery and genotyping using next-generation DNA sequencing data
DePristo, M. A., Banks, E., Poplin, R. E., Garimella, K. V., Maguire, J., Hartl, C., Philippakis, A., del Angel, G., Rivas, M. A., Hanna, M., et al. (2011) · Nature Genetics · doi:10.1038/ng.806 · Cited by 11,457
Self-citationRare-Variant Association Testing for Sequencing Data with the Sequence Kernel Association Test
Wu, M. C., Lee, S., Cai, T., Li, Y., Boehnke, M., & Lin, X. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.05.029 · Cited by 2,373
Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations
O’Roak, B. J., Vives, L., Girirajan, S., Karakoc, E., Krumm, N., Coe, B. P., Levy, R., Ko, A., Lee, C., Smith, J. D., et al. (2012) · Nature · doi:10.1038/nature10989 · Cited by 2,165
De novo mutations revealed by whole-exome sequencing are strongly associated with autism
Sanders, S. J., Murtha, M. T., Gupta, A. R., Murdoch, J. D., Raubeson, M. J., Willsey, A. J., Ercan-Sencicek, A. G., DiLullo, N. M., Parikshak, N. N., Stein, J. L., et al. (2012) · Nature · doi:10.1038/nature10945 · Cited by 2,084
Self-citationFunctional impact of global rare copy number variation in autism spectrum disorders
Pinto, D., Pagnamenta, A. T., Klei, L., Anney, R., Merico, D., Regan, R., Conroy, J., Magalhaes, T. R., Correia, C., Abrahams, B. S., et al. (2010) · Nature · doi:10.1038/nature09146 · Cited by 2,013 · cited 1×
“Copy number variants (CNVs), often de novo and covering multiple adjacent genes, have been identified as conferring risk 3,4 .”
BackgroundSelf-citationGenetic Heritability and Shared Environmental Factors Among Twin Pairs With Autism
Hallmayer, J. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.76 · Cited by 1,970
Cited by
Sorted by citations
Items 201–300 of 1,004
Brain Transcriptional and Epigenetic Associations with Autism
Ginsberg, M. R., Rubin, R. A., Falcone, T., Ting, A. H., & Natowicz, M. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044736 · Cited by 164
Zhang, Y., Li, N., Li, C., Zhang, Z., Teng, H., Wang, Y., Zhao, T., Shi, L., Zhang, K., Xia, K., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0699-8 · Cited by 177
Self-citationLionel, A. C., Tammimies, K., Vaags, A. K., Rosenfeld, J. A., Ahn, J. W., Merico, D., Noor, A., Runke, C. K., Pillalamarri, V. K., Carter, M. T., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt669 · Cited by 163
Autism spectrum disorder in the genetics clinic: a review
Carter, M., & Scherer, S. W. (2013) · Clinical Genetics · doi:10.1111/cge.12101 · Cited by 190
Nitarska, J., Smith, J. G., Sherlock, W. T., Hillege, M. M., Nott, A., Barshop, W. D., Vashisht, A. A., Wohlschlegel, J. A., Mitter, R., & Riccio, A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.10.022 · Cited by 181
Wang, P., Lin, M., Pedrosa, E., Hrabovsky, A., Zhang, Z., Guo, W., Lachman, H. M., & Zheng, D. (2015) · Molecular Autism · doi:10.1186/s13229-015-0048-6 · Cited by 171
Wnt signaling networks in autism spectrum disorder and intellectual disability
Kwan, V., Unda, B. K., & Singh, K. K. (2016) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-016-9176-3 · Cited by 176
Dong, S., Walker, M. F., Carriero, N. J., DiCola, M. J., Willsey, A. J., Ye, A. Y., Waqar, Z., González, L. E., Overton, J. D., Frahm, S., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.068 · Cited by 175
Self-citationNovel variation and de novo mutation rates in population-wide de novo assembled Danish trios
Besenbacher, S., Liu, S. M., Izarzugaza, J. M. G., Grove, J., Belling, K., Bork‐Jensen, J., Huang, S., Als, T. D., Li, S., Yadav, R., et al. (2015) · Nature Communications · doi:10.1038/ncomms6969 · Cited by 169
Self-citationThe Diverse Genetic Landscape of Neurodevelopmental Disorders
Hu, W. F., Chahrour, M. H., & Walsh, C. A. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025600 · Cited by 177
Takata, A., Miyake, N., Tsurusaki, Y., Fukai, R., Miyatake, S., Koshimizu, E., Kushima, I., Okada, T., Morikawa, M., Uno, Y., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2017.12.074 · Cited by 174
Genetics of glutamate and its receptors in autism spectrum disorder
Nisar, S., Bhat, A. A., Masoodi, T., Hashem, S., Akhtar, S., Ali, T. A., Amjad, S., Chawla, S., Bagga, P., Frenneaux, M. P., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01506-w · Cited by 189
Tipping the balance of autism risk: potential mechanisms linking pesticides and autism
Shelton, J. F., Hertz-Picciotto, I., & Pessah, I. N. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104553 · Cited by 164
Using deep mutational scanning to benchmark variant effect predictors and identify disease mutations
Livesey, B., & Marsh, J. A. (2020) · Molecular Systems Biology · doi:10.15252/msb.20199380 · Cited by 164
Poultney, C. S., Goldberg, A. P., Drapeau, E., Kou, Y., Harony-Nicolas, H., Kajiwara, Y., De Rubeis, S., Durand, S., Stevens, C., Rehnström, K., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.09.001 · Cited by 169
Self-citationFLAGS, frequently mutated genes in public exomes
Shyr, C., Tarailo‐Graovac, M., Gottlieb, M., Lee, J. J. Y., van Karnebeek, C., & Wasserman, W. W. (2014) · BMC Medical Genomics · doi:10.1186/s12920-014-0064-y · Cited by 174
Wang, X., Xu, Q., Bey, A. L., Lee, Y., & Jiang, Y. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-30 · Cited by 173
Howrigan, D. P., Rose, S. A., Samocha, K. E., Fromer, M., Cerrato, F., Chen, W. J., Churchhouse, C., Chambert, K., Chandler, S. D., Daly, M. J., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-019-0564-3 · Cited by 168
Self-citationLuo, R., Sanders, S. J., Tian, Y., Voineagu, I., Huang, N., Chu, S. H., Klei, L., Cai, C., Ou, J., Lowe, J. K., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.05.011 · Cited by 167
Self-citationSomatic gain-of-function mutations in PIK3CA in patients with macrodactyly
Rios, J. J., Paria, N., Burns, D. K., Israel, B. A., Cornelia, R., Wise, C. A., & Ezaki, M. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds440 · Cited by 167
Dissection of genetic factors associated with amyotrophic lateral sclerosis
Leblond, C. S., Kaneb, H., Dion, P. A., & Rouleau, G. A. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.04.013 · Cited by 175
The Emerging Biology of Autism Spectrum Disorders
State, M. W., & Šestan, N. (2012) · Science · doi:10.1126/science.1224989 · Cited by 164
Grozeva, D., Carss, K., Spasić-Bošković, O., Parker, M. J., Archer, H. L., Firth, H. V., Park, S., Canham, N. L. E., Holder, S., Wilson, M., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.03.006 · Cited by 168
Regulation of histone H3K4 methylation in brain development and disease
Shen, E., Shulha, H. P., Weng, Z., & Akbarian, S. (2014) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2013.0514 · Cited by 167
Gussow, A. B., Copeland, B. R., Dhindsa, R. S., Wang, Q., Petrovski, S., Majoros, W. H., Allen, A. S., & Goldstein, D. B. (2017) · PLoS ONE · doi:10.1371/journal.pone.0181604 · Cited by 165
Uddin, M., Tammimies, K., Pellecchia, G., Alipanahi, B., Hu, P., Wang, Z., Pinto, D., Lau, L., Nalpathamkalam, T., Marshall, C. R., et al. (2014) · Nature Genetics · doi:10.1038/ng.2980 · Cited by 163
The Emerging Clinical Neuroscience of Autism Spectrum Disorder
Muhle, R., Reed, H. E., Stratigos, K. A., & Veenstra-VanderWeele, J. M. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.4685 · Cited by 176
Fernandez, B. A., & Scherer, S. W. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.4/sscherer · Cited by 169
Autism Risk Across Generations
Frans, E. M., Sandin, S., Reichenberg, A., Långström, N., Lichtenstein, P., McGrath, J. J., & Hultman, C. M. (2013) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.1180 · Cited by 167
Disruption of POGZ Is Associated with Intellectual Disability and Autism Spectrum Disorders
Stessman, H. A. F., Willemsen, M. H., Fencková, M., Penn, O., Hoischen, A., Xiong, B., Wang, T., Hoekzema, K., Vives, L., Vogel, I., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.02.004 · Cited by 160
Brain connectivity in autism spectrum disorder
Mohammad-Rezazadeh, I., Frohlich, J., Loo, S. K., & Jeste, S. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000301 · Cited by 163
Low load for disruptive mutations in autism genes and their biased transmission
Iossifov, I., Levy, D., Allen, J., Ye, K., Ronemus, M., Lee, Y.-H., Yamrom, B., & Wigler, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516376112 · Cited by 156
DiCarlo, G. E., Aguilar, J. I., Matthies, H. J. G., Harrison, F. E., Bundschuh, K. E., West, A. M., Hashemi, P., Herborg, F., Rickhag, M., Chen, H., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci127411 · Cited by 150
Robinson, E. B., Samocha, K. E., Kosmicki, J. A., McGrath, L., Neale, B. M., Perlis, R. H., & Daly, M. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409204111 · Cited by 142
Self-citationNeocortical neurogenesis and the etiology of autism spectrum disorder
Packer, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.002 · Cited by 138
De Novo Mutation in Genes Regulating Neural Stem Cell Fate in Human Congenital Hydrocephalus
Furey, C. G., Choi, J., Jin, S. C., Zeng, X. Q., Timberlake, A. T., Nelson-Williams, C. J., Mansuri, M. S., Lu, Q., Durán, D., Panchagnula, S., et al. (2018) · Neuron · doi:10.1016/j.neuron.2018.06.019 · Cited by 148
Katyal, S., Lee, Y., Nitiss, K. C., Downing, S. M., Li, Y., Shimada, M., Zhao, J., Russell, H. R., Petrini, J. H. J., Nitiss, J. L., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3715 · Cited by 152
Autism spectrum disorders: from genes to neurobiology
Jeremy Willsey, A., & State, M. W. (2015) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.10.015 · Cited by 145
The role of BAF (mSWI/SNF) complexes in mammalian neural development
Son, E., & Crabtree, G. R. (2014) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.31416 · Cited by 148
Feng, W., Khan, M. A., Bellvís, P., Zhu, Z., Bernhardt, O., Herold‐Mende, C. C., & Liu, H. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.05.002 · Cited by 154
Self-citationExome sequencing to identify de novo mutations in sporadic ALS trios
Chesi, A., Staahl, B. T., Jovičić, A., Couthouis, J., Fasolino, M., Raphael, A. R., Yamazaki, T., Elias, L., Polak, M. A., Kelly, C. M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3412 · Cited by 149
Bhandari, R., Paliwal, J. K., & Kuhad, A. (2020) · Advances in neurobiology · doi:10.1007/978-3-030-30402-7_4 · Cited by 167
Genetic and Epigenetic Etiology Underlying Autism Spectrum Disorder
Yoon, S. H., Choi, J., Lee, W. Y., & Do, J. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040966 · Cited by 175
Self-citationPrioritization of neurodevelopmental disease genes by discovery of new mutations
Hoischen, A., Krumm, N., & Eichler, E. E. (2014) · Nature Neuroscience · doi:10.1038/nn.3703 · Cited by 149
Ben-David, E., & Shifman, S. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.148 · Cited by 148
Marangi, G., & Traynor, B. J. (2014) · Brain Research · doi:10.1016/j.brainres.2014.10.009 · Cited by 155
Lage, K., Greenway, S. C., Rosenfeld, J. A., Wakimoto, H., Gorham, J., Segrè, A. V., Roberts, A. E., Smoot, L. B., Pu, W. T., Pereira, A. C., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1210730109 · Cited by 148
Self-citationAutism Spectrum Disorder Genetics and the Search for Pathological Mechanisms
Manoli, D. S., & State, M. W. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20111608 · Cited by 159
New and emerging approaches to treat psychiatric disorders
Scangos, K. W., State, M. W., Miller, A. H., Baker, J. T., & Williams, L. M. (2023) · Nature Medicine · doi:10.1038/s41591-022-02197-0 · Cited by 164
Autism Spectrum Disorder and Epilepsy
Jeste, S., & Tuchman, R. F. (2015) · Journal of Child Neurology · doi:10.1177/0883073815601501 · Cited by 147
Zinc: An underappreciated modulatory factor of brain function
Marger, L., Schubert, C. R., & Bertrand, D. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2014.08.002 · Cited by 150
Blumenthal, I., Ragavendran, A., Erdin, S., Klei, L., Sugathan, A., Guide, J. R., Manavalan, P., Zhou, J. Q., Wheeler, V. C., Levin, J. Z., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.05.004 · Cited by 145
Self-citationGene Length Matters in Neurons
Zylka, M. J., Simon, J. M., & Philpot, B. D. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.059 · Cited by 148
Janecka, M., Mill, J., Basson, M. A., Goriely, A., Spiers, H., Reichenberg, A., Schalkwyk, L., & Fernandes, C. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.294 · Cited by 140
Recurrent de novo mutations in neurodevelopmental disorders: properties and clinical implications
Wilfert, A. B., Sulovari, A., Turner, T. N., Coe, B. P., & Eichler, E. E. (2017) · Genome Medicine · doi:10.1186/s13073-017-0498-x · Cited by 144
High Loading of Polygenic Risk for ADHD in Children With Comorbid Aggression
Hamshere, M. L., Langley, K., Martin, J., Agha, S. S., Stergiakouli, E., Anney, R. J. L., Buitelaar, J., Faraone, S. V., Lesch, K.-P., Neale, B. M., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.12081129 · Cited by 144
Self-citationRecapitulation and Reversal of Schizophrenia-Related Phenotypes in Setd1a-Deficient Mice
Mukai, J., Cannavò, E., Crabtree, G. W., Sun, Z., Diamantopoulou, A., Thakur, P., Chang, C., Cai, Y., Lomvardas, S., Takata, A., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.09.014 · Cited by 146
Autism-Associated Promoter Variant in MET Impacts Functional and Structural Brain Networks
Rudie, J. D., Hernandez, L. M., Brown, J. A., Beck-Pancer, D., Colich, N. L., Gorrindo, P., Thompson, P. M., Geschwind, D. H., Bookheimer, S. Y., Levitt, P., et al. (2012) · Neuron · doi:10.1016/j.neuron.2012.07.010 · Cited by 142
Predicting the diagnosis of autism spectrum disorder using gene pathway analysis
Skafidas, E. S., Testa, R., Zantomio, D., Chana, G., Everall, I., & Pantelis, C. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.126 · Cited by 148
Aceti, M., Creson, T. K., Vaissiere, T., Rojas, C., Huang, W.-C., Wang, Y.-X., Petralia, R. S., Page, D. T., Miller, C. A., & Rumbaugh, G. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.08.001 · Cited by 129
The mutation rate in human evolution and demographic inference
Scally, A. (2016) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2016.07.008 · Cited by 145
Understanding sex bias in autism spectrum disorder
Werling, D. M., & Geschwind, D. H. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1301602110 · Cited by 135
Corominas, R., Yang, X., Lin, G. N., Kang, S., Shen, Y., Ghamsari, L., Broly, M., Rodriguez, M., Tam, S., Wanamaker, S. A., et al. (2014) · Nature Communications · doi:10.1038/ncomms4650 · Cited by 140
“The ASIN-based sources of evidence included: (1) preys binding to a significantly greater than expected number of ASIN baits from the de novo autism CNVs identified from the CNV–prey network (a total of 26); (2) preys significantly enriched in ‘SNARE/syntaxin binding’ and ‘transcription factor binding’ from the gene c…”
Integrated systems analysis reveals a molecular network underlying autism spectrum disorders
Li, J., Shi, M., Ma, Z., Zhao, S., Euskirchen, G., Ziskin, J., Urban, A., Hallmayer, J., & Snyder, M. (2014) · Molecular Systems Biology · doi:10.15252/msb.20145487 · Cited by 132
“Overall, these observations revealed the modular architecture of the human protein interactome, with different modules organized for specific functions (Supplementary Fig S5).”
Genetic aspects of autism spectrum disorders: insights from animal models
Banerjee, S., Riordan, M., & Bhat, M. A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00058 · Cited by 156
Scheckel, C., Drapeau, E., Frias, M. A., Park, C. Y., Fak, J., Zucker-Scharff, I., Kou, Y., Haroutunian, V., Ma'ayan, A., Buxbaum, J. D., et al. (2016) · eLife · doi:10.7554/elife.10421 · Cited by 139
Self-citationExome sequencing and complex disease: practical aspects of rare variant association studies
Do, R., Kathiresan, S., & Abecasis, G. R. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds387 · Cited by 143
Epigenetic Regulations in Neuropsychiatric Disorders
Kuehner, J. N., Bruggeman, E. C., Wen, Z., & Yao, B. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00268 · Cited by 144
Liu, L., Sabo, A., Neale, B. M., Nagaswamy, U., Stevens, C., Lim, E., Bodea, C. A., Muzny, D., Reid, J. G., Banks, E., et al. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003443 · Cited by 135
Self-citationDAWN: a framework to identify autism genes and subnetworks using gene expression and genetics
Liu, L., Lei, J., Sanders, S., Willsey, A. J., Kou, Y., Cicek, A. E., Klei, L., Lu, C., He, X., Li, M., et al. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-22 · Cited by 135
Self-citationOne gene, many neuropsychiatric disorders: lessons from Mendelian diseases
Zhu, X., Need, A. C., Petrovski, S., & Goldstein, D. B. (2014) · Nature Neuroscience · doi:10.1038/nn.3713 · Cited by 131
Duncan, L. E., Pollastri, A. R., & Smoller, J. W. (2014) · American Psychologist · doi:10.1037/a0036320 · Cited by 145
DNA Methylation and Susceptibility to Autism Spectrum Disorder
Tremblay, M. W., & Jiang, Y. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-120417-091431 · Cited by 139
Genetics of recessive cognitive disorders
Musante, L., & Ropers, H. (2013) · Trends in Genetics · doi:10.1016/j.tig.2013.09.008 · Cited by 144
Recent developments in the genetics of autism spectrum disorders
Murdoch, J. D., & State, M. W. (2013) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.02.003 · Cited by 138
Validation and assessment of variant calling pipelines for next-generation sequencing
Pirooznia, M., Kramer, M., Parla, J. S., Goes, F. S., Potash, J. B., McCombie, W. R., & Zandi, P. P. (2014) · Human Genomics · doi:10.1186/1479-7364-8-14 · Cited by 132
Codina‐Solà, M., Rodríguez‐Santiago, B., Homs, A., Santoyo‐López, J., Rigau, M., Laín, G. A., Campo, M. D., Gener, B., Gabau, E., Botella, M. P., et al. (2015) · Molecular Autism · doi:10.1186/s13229-015-0017-0 · Cited by 137
The effects of advanced paternal age on fertility
Kovac, J. R., Addai, J. B., Smith, R. P., Coward, R. M., Lamb, D. J., & Lipshultz, L. I. (2013) · Asian Journal of Andrology · doi:10.1038/aja.2013.92 · Cited by 147
The Contribution of Mosaic Variants to Autism Spectrum Disorder
Freed, D. N., & Pevsner, J. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1006245 · Cited by 128
Hertz‐Picciotto, I., Schmidt, R. J., Walker, C. K., Bennett, D. H., Oliver, M., Shedd-Wise, K. M., LaSalle, J. M., Giulivi, C., Puschner, B., Thomas, J. E., et al. (2018) · Environmental Health Perspectives · doi:10.1289/ehp535 · Cited by 134
Suetterlin, P., Hurley, S., Mohan, C., Riegman, K. L. H., Pagani, M., Caruso, A., Ellegood, J., Galbusera, A., Crespo‐Enríquez, I., Michetti, C., et al. (2018) · Cerebral Cortex · doi:10.1093/cercor/bhy058 · Cited by 132
The Intolerance of Regulatory Sequence to Genetic Variation Predicts Gene Dosage Sensitivity
Petrovski, S., Gussow, A. B., Wang, Q., Halvorsen, M., Han, Y., Weir, W. H., Allen, A. S., & Goldstein, D. B. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005492 · Cited by 132
Self-citationTakata, A., Ionita‐Laza, I., Gogos, J. A., Xu, B., & Karayiorgou, M. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.024 · Cited by 129
An assessment of sex bias in neurodevelopmental disorders
Polyak, A., Rosenfeld, J. A., & Girirajan, S. (2015) · Genome Medicine · doi:10.1186/s13073-015-0216-5 · Cited by 129
O'Rawe, J., Wu, Y., Dörfel, M. J., Rope, A. F., Au, P. Y. B., Parboosingh, J. S., Moon, S., Kousi, M., Kosma, K., Smith, C., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.11.005 · Cited by 129
Self-citationWhole-genome analyses of whole-brain data: working within an expanded search space
Medland, S. E., Jahanshad, N., Neale, B. M., & Thompson, P. M. (2014) · Nature Neuroscience · doi:10.1038/nn.3718 · Cited by 119
Self-citationSestan, N., & State, M. W. (2018) · Neuron · doi:10.1016/j.neuron.2018.10.015 · Cited by 127
Merner, N. D., Chandler, M. R., Bourassa, C. V., Liang, B., Khanna, A. R., Dion, P. A., Rouleau, G. A., & Kahle, K. T. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00386 · Cited by 129
Rodin, R. E., Dou, Y., Kwon, M., Sherman, M. A., D’Gama, A. M., Doan, R. N., Rento, L. M., Girskis, K. M., Bohrson, C. L., Kim, S. N., et al. (2021) · Nature Neuroscience · doi:10.1038/s41593-020-00765-6 · Cited by 135
Self-citationBowton, E., Saunders, C., Reddy, I. A., Campbell, N. G., Hamilton, P. J., Henry, L. K., Coon, H. H., Sakrikar, D. S., Veenstra-VanderWeele, J. M., Blakely, R., et al. (2014) · Translational Psychiatry · doi:10.1038/tp.2014.90 · Cited by 119
Self-citationRegulation of neuronal migration, an emerging topic in autism spectrum disorders
Reiner, O., Karzbrun, E., Kshirsagar, A., & Kaibuchi, K. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13403 · Cited by 129
Whole-genome and whole-exome sequencing in neurological diseases
Foo, J. N., Liu, J., & Tan, E. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.148 · Cited by 124
What is the role of vitamin D in autism?
Cannell, J. J., & Grant, W. B. (2013) · Dermato-Endocrinology · doi:10.4161/derm.24356 · Cited by 124
Human-Specific Histone Methylation Signatures at Transcription Start Sites in Prefrontal Neurons
Shulha, H. P., Crisci, J. L., Reshetov, D. A., Tushir, J. S., Cheung, I. K., Bharadwaj, R. A., Chou, H.-J., Houston, I. B., Peter, C. J., Mitchell, A., et al. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001427 · Cited by 124
Potential serum biomarkers from a metabolomics study of autism
Wang, H., Liang, S., Wang, M., Gao, J., Sun, C., Wang, J., Xia, W. T., Wu, S., Sumner, S., Zhang, F., et al. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140009 · Cited by 121
The contributions of rare inherited and polygenic risk to ASD in multiplex families
Cirnigliaro, M., Chang, T. S., Arteaga, S. A., Pérez‐Cano, L., Ruzzo, E. K., Gordon, A., Bicks, L. K., Jung, J.-Y., Lowe, J. K., Wall, D. P., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2215632120 · Cited by 124
Protein–protein interactions and genetic diseases: The interactome
Lage, K. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.05.028 · Cited by 125
Risk of psychiatric illness from advanced paternal age is not predominantly from de novo mutations
Gratten, J., Wray, N. R., Peyrot, W. J., McGrath, J. J., Visscher, P. M., & Goddard, M. E. (2016) · Nature Genetics · doi:10.1038/ng.3577 · Cited by 118
A twin study of heritable and shared environmental contributions to autism
Frazier, T. W., Thompson, L., Youngstrom, E. A., Law, P., Hardan, A. Y., Eng, C., & Morris, N. (2014) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-014-2081-2 · Cited by 120
Mutations ofANK3identified by exome sequencing are associated with autism susceptibility
Bi, C., Wu, J., Jiang, T., Liu, Q., Cai, W., Yu, P., Cai, T., Zhao, M., Jiang, Y., & Sun, Z. S. (2012) · Human Mutation · doi:10.1002/humu.22174 · Cited by 120
Metadata
- Authors
- Neale, B. M., Kou, Y., Liu, L., Ma’ayan, A., Samocha, K. E., Sabo, A., Lin, C.-F., Stevens, C., Wang, L.-S., Makarov, V., Polak, P., Yoon, S., Maguire, J., Crawford, E. L., Campbell, N. G., Geller, E. T., Valladares, O., Schafer, C., Liu, H., Zhao, T., Cai, G., Lihm, J., Dannenfelser, R., Jabado, O., Peralta, Z., Nagaswamy, U., Muzny, D., Reid, J. G., Newsham, I., Wu, Y., Lewis, L., Han, Y., Voight, B. F., Lim, E., Rossin, E., Kirby, A., Flannick, J., Fromer, M., Shakir, K., Fennell, T., Garimella, K., Banks, E., Poplin, R., Gabriel, S., DePristo, M., Wimbish, J. R., Boone, B. E., Levy, S. E., Betancur, C., Sunyaev, S., Boerwinkle, E., Buxbaum, J. D., Cook Jr, E. H., Devlin, B., Gibbs, R. A., Roeder, K., Schellenberg, G. D., Sutcliffe, J. S., & Daly, M. J.
- Affiliations
- Harvard University (US)
- Icahn School of Medicine at Mount Sinai (US)
- Carnegie Mellon University (US)
- Broad Institute (US)
- Baylor College of Medicine (US)
- University of Pennsylvania (US)
- Vanderbilt University (US)
- Johns Hopkins University (US)
- HudsonAlpha Institute for Biotechnology (US)
- Centre National de la Recherche Scientifique (FR)
- University of Pittsburgh (US)
- Corresponding author
- Buxbaum, Joseph D.
- Roeder, Kathryn
- Daly, Mark J.
- ORCID
- Neale, Benjamin M.
- Liu, Li
- Ma’ayan, Avi
- Samocha, Kaitlin E.
- Sabo, Aniko
- Lin, Chiao-Feng
- Stevens, Christine
- Makarov, Vladimir
- Polak, Paz
- Geller, Evan T.
- Valladares, Otto
- Liu, Han
- Zhao, Tuo
- Lihm, Jayon
- Dannenfelser, Ruth
- Muzny, Donna
- Reid, Jeffrey G.
- Newsham, Irene
- Wu, Yuanqing
- Han, Yi
- Voight, Benjamin F.
- Lim, Elaine
- Rossin, Elizabeth
- Flannick, Jason
- Fromer, Menachem
- Fennell, Tim
- Garimella, Kiran
- Banks, Eric
- Gabriel, Stacey
- Levy, Shawn E.
- Betancur, Catalina
- Sunyaev, Shamil
- Boerwinkle, Eric
- Buxbaum, Joseph D.
- Devlin, Bernie
- Gibbs, Richard A.
- Roeder, Kathryn
- Schellenberg, Gerard D.
- Sutcliffe, James S.
- Daly, Mark J.
- Venue
- Nature
- Published
- 2012-04-04
- Volume
- 485
- Issue
- 7397
- Pages
- 242-245
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3613847
- OpenAlex
- W2024663595
- Semantic Scholar
- 7597cd398ad2874b3c231d70f97956fb53b1be57
- Cited by
- 1,734
- References
- 27
- Citations by year
- 2026: 32 · 2025: 44 · 2024: 56 · 2023: 56 · 2022: 75 · 2021: 99 · 2020: 110 · 2019: 121 · 2018: 125 · 2017: 144 · 2016: 158 · 2015: 180 · 2014: 245 · 2013: 194 · 2012: 92
- FWCI
- 116.56
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- HAL (submittedVersion, other-oa)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Vanderbilt University (UL1 RR024975)
- National Institutes of Health (MH057881, HD015052, HD055751, RR024975)
- Vanderbilt Kennedy Center, Vanderbilt University Medical Center
- National Institute of Mental Health (R01MH061009, R01MH089025, R01MH089175, R01MH089004, R01MH089208, R01MH057881, MH057881, R01MH089482, R01MH084676)
- National Human Genome Research Institute (U54HG003067, HG003273, U54HG003273)
- National Institute of General Medical Sciences (T32GM007753, P50GM071558)
- National Center for Research Resources (RR024975, KL2RR024977, TL1RR024978, UL1RR024975)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (P30HD015052, P50HD055751)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomics and Rare Diseases
- Keywords
- autism spectrum disorder, genetic heterogeneity, locus heterogeneity, polygenic risk, parent-child trios, exome sequencing, protein-protein interaction network, SCN2A, CHD8, β-catenin signaling, p53 pathway, mutation rate, penetrance, copy number variation, genetic risk
- MeSH terms
- Autistic Disorder, DNA-Binding Proteins, Exons, Family Health, Humans, Models, Genetic, Mutation, Phenotype, Transcription Factors, Poisson Distribution, Case-Control Studies, Genetic Predisposition to Disease, Multifactorial Inheritance, Exome, Protein Interaction Maps
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
